| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2075726 | BioMedicine | 2013 | 6 Pages |
Abstract
This PA-free ONS was safe and well tolerated with PIDD. It seemed to benefit quality of life and control pain. The effects were dose dependent, with maximum improvement observed during the first 5 weeks when PA depletion was maximal.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Bernard Cipolla, Jean-Yves Bansard, J. Pierre Ecalard, Jacques-Philippe Moulinoux,